SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-089657
Filing Date
2013-12-11
Accepted
2013-12-11 16:15:49
Documents
2
Period of Report
2013-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-26131_18k.htm 8-K 24873
2 EX-99.1 a13-26131_1ex99d1.htm EX-99.1 7274
  Complete submission text file 0001104659-13-089657.txt   33480
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 131271123
SIC: 2834 Pharmaceutical Preparations